Science & Enterprise subscription

Follow us on Twitter

  • Results of a pilot test show a smartphone app makes a common test for the pregnancy complication preeclampsia simpl… https://t.co/AN5bKtBQrG
    about 6 hours ago
  • New post on Science and Enterprise: App Automates, Simplifies Test for Preeclampsia https://t.co/lSyEXavP4X #Science #Business
    about 6 hours ago
  • Computer scientists in the U.K. and France created techniques for adding a refined sense of touch to highly sensiti… https://t.co/ilWVpMNqZb
    about 13 hours ago
  • New post on Science and Enterprise: Touch Senses Added to Synthetic Skin, Robot Arm https://t.co/KMpa31SgZP #Science #Business
    about 13 hours ago
  • The NBI is in decline since reaching its peak for the year in the spring, erasing all of the gains for the year at… https://t.co/PF5ud7Vlk3
    about 2 days ago

Please share Science & Enterprise

Implanted Overdose Rescue Device Being Developed

Overdose rescue device

An implanted device that senses an overdose of opioid drugs and dispenses an emergency rescue medicine is in development by two university labs. . . . → Read More: Implanted Overdose Rescue Device Being Developed

Early Results Show Anti-Depressive Drug Effects

Man with depression

Initial results from a clinical trial show a drug designed to supplement first-line treatments helps reduce symptoms of major depressive disorder. . . . → Read More: Early Results Show Anti-Depressive Drug Effects

Real-World Evidence Assessed for Cancer Drug Trials

Assorted medical tools

Two medical technology companies are evaluating real-world evidence from patients to simulate randomized clinical trials for testing new cancer treatments. . . . → Read More: Real-World Evidence Assessed for Cancer Drug Trials

Trial to Test CBD for Parkinson’s-Related Psychosis

Cannabis plant

A clinical trial is planned to test cannabidiol, or CBD, derived from cannabis as a treatment for hallucinations and delusions among people with Parkinson’s disease. . . . → Read More: Trial to Test CBD for Parkinson’s-Related Psychosis

Nanoparticles Designed to Cross Blood-Brain Barrier

Neurons

Nanoscale particles derived from viruses are shown in tests with lab mice to cross the blood-brain barrier, and reach nerve cells in the brain. . . . → Read More: Nanoparticles Designed to Cross Blood-Brain Barrier

Companies Developing Hemophilia Gene Editing Therapy

Mountain bluebird

A partnership between drug maker Novo Nordisk and biotechnology company bluebird bio is designing a treatment for hemophilia with gene-editing proteins. . . . → Read More: Companies Developing Hemophilia Gene Editing Therapy

Merck Gaining Gut Microbe Technology for Vaccines

Microbiome graphic

Drug maker Merck & Co. is partnering with a developer of treatments for disease derived from microbes in the gut, for discovery of up to three vaccines. . . . → Read More: Merck Gaining Gut Microbe Technology for Vaccines

Dementia Drug Candidate in Preclinical Tests

Linda Van Eldik

A study is underway of a new treatment approach for dementia that targets inflammation and microscopic bleeding in the brain that can accompany Alzheimer’s disease. . . . → Read More: Dementia Drug Candidate in Preclinical Tests

Nanotech Crispr Delivery in Development

Editing a DNA strand

Researchers in biochemistry and structural biology are designing a technique using nanoscale particles to safely deliver edited genes as a cancer treatment. . . . → Read More: Nanotech Crispr Delivery in Development

Novartis, Microsoft Partner on A.I.

Artificial intelligence graphic

Drug maker Novartis is collaborating with Microsoft to extend the company’s adoption of artificial intelligence into many of its corporate functions. . . . → Read More: Novartis, Microsoft Partner on A.I.